Ranbaxy eyes U.S. drug launches with sales exclusivity

A general view of the office of Ranbaxy Laboratories is pictured at GurgaonMUMBAI (Reuters) – Ranbaxy Laboratories, India's No.1 drugmaker by sales, plans to file three to four generic drug applications every year that can earn it a six-month marketing exclusivity in the United States, the company's chief executive said on Thursday. The first company that seeks approval from the U.S. Food and Drug Administration for a generic version of a patented medicine gets exclusive rights to sell it for 180 days after patent expiry. "We have a very ambitious growth plan for our U.S. …

Pennsylvania girl who got lung transplant after judge’s order out of surgery

(Reuters) – The mother of a 10-year-old Pennsylvania girl with cystic fibrosis, who only became eligible for an adult organ transplant because of a judge’s order, said on Wednesday her daughter was out of surgery after a double-lung transplant from an adult donor and doing well. Sarah Murnaghan, who had been kept off an adult organ transplant list due to an age restriction prior to the judge’s ruling, was undergoing transplant surgery at Children’s Hospital of Philadelphia, said family spokeswoman Tracy Simon. …

Mother says Pennsylvania girl’s lung transplant a success

(Reuters) – A 10-year-old Pennsylvania girl with cystic fibrosis who only became eligible for an adult organ transplant because of a federal judge’s order is out of surgery after a double-lung transplant on Wednesday and doing well, her mother said. Janet Murnaghan wrote on Facebook that her daughter Sarah Murnaghan was recovering in the intensive care unit after the six-hour procedure that began at 11 a.m. local time at Children’s Hospital of Philadelphia. …

1 56 57 58 59 60 101